Literature DB >> 11071956

Managing phosphate retention: is a change necessary?

I B Salusky, W G Goodman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11071956     DOI： 10.1093/ndt/15.11.1738

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

Review 1.  Paricalcitol: a review of its use in the management of secondary hyperparathyroidism.

Authors:  Dean M Robinson; Lesley J Scott
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Klotho deficiency causes vascular calcification in chronic kidney disease.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Carolyn Griffith; Makoto Kuro-o; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

3.  Progression of coronary calcification in pediatric chronic kidney disease stage 5.

Authors:  Mahmut Civilibal; Salim Caliskan; Sebuh Kurugoglu; Cengiz Candan; Nur Canpolat; Lale Sever; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-11-04       Impact factor: 3.714

4.  Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value.

Authors:  Carole Nadin
Journal:  Core Evid       Date:  2005-03-31

Review 5.  Klotho: a humeral mediator in CSF and plasma that influences longevity and susceptibility to multiple complex disorders, including depression.

Authors:  M G Pavlatou; A T Remaley; P W Gold
Journal:  Transl Psychiatry       Date:  2016-08-30       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.